Printer Friendly


Byline: Naseer Ahmad Samore, Hafsa Khalil, Sohail Aziz, Fida Hussain, Safdar Abbas and Imran Fazal


Objective: To determine the primary and secondary outcomes of primary percutaneous coronary interventions (PCI) in ST segment elevation myocardial infarction and to measure the success rate of primary PCI procedure at AFIC/NIHD.

Study Design: A descriptive cross-sectional study.

Materials and Methods: The study was conducted in the Cardiology department of AFIC/NIHD, a tertiary care cardiac institute at Rawalpindi. The data was collected from an ongoing registry. It is an update on procedural outcome of PPCI over the 4 year duration from October 2011 to January 2016. Total 2136 patients who underwent primary PCI were included in this study. Procedural outcome, success and in hospital mortality were notable variables.

Results: The mean age was 59 +- 10.88 years. Patients of age group 58-75 and above 75 year were having high mortality rate of 2.1% and 2.5% respectively (p-value<0.783). There were 1975 (92.3%) males and 164 (7.7%) female. 378 (17.6%) patients were found to be diabetic (p<0.554), 608 (28.4%) hypertensive (p<0.736), and 637 (29.7%) patients were smokers (p<0.868). Family history of ischemic heart disease was positive in 323 (15.1%) patients, which is a significant factor with the p-value=0.028. Anterior, inferior and lateral myocardial infarction was present in 1116 (53.8%), 920 (44.3%) and 19 (0.9%) patients respectively (p<0.800). The Median time from the onset of symptoms to the arrival in the hospital was 210 +- 562.8 min (p< 0.001) and median door to balloon time was 56.25 +- 2.6 min (p<0.566).

Left anterior descending (LAD) was the culprit artery in 1115 (56.1%) patients followed by right coronary artery (RCA) 659 (33.2%) and left circumflex artery (LCX) in 174 (8.8%) cases (p<0.001). 44 (2.1%) patients died in the hospital.

Conclusion: High success rate with low mortality rates can be achieved in our set up. However more studies and long term follow up is required to validate our results.

Keywords: Primary percutaneous coronary intervention (P.PCI), ST segment elevation myocardial infarction (STEMI).


The coronary arteries disease (CAD) is the most leading cause of death throughout the world. In which almost half of the cases occurs in Asia1,2. Smoking and obesity like risk factors are becoming more frequent with increased concern in developing countries 1.

Myocardial infarction is the result of increased myocardial metabolism demand, decreased delivery of oxygen and nutrients to myocardium through coronary circulation due to rupture or ulceration of unstable atherosclerotic plaque resulting in occlusion of vessels causing infraction of subjacent myocardium3.

PPCI is a farm of coronary reperfusion therapy which is preferred in patients with chest pain consistent with myocardial infarction of duration <12 hours with associated ST-segment elevation in ECG performed by experienced operators under guideline mandated time. Superiority of PPCI on hospital fibrinolysis in PCI capable centers is shown in many randomized trials4,10. But this is still not commonly adapted in this part of the world and only few of the patients get this privilege after reporting to PPCI capable centers. Thus this causes the shortage of data availability from this part of the world. AFIC and NIHD started primary PCI program that commenced from 2011 during the working hours in the day time and then extending the availability of PPCI facility to the off hours. The basic purpose of the study is to know the outcome of PPCI in our center5,7.

Procedural success of primary PCI was defined as achievement of vessel patency with TIMI 3 flow and residual stenosis of <0%. Time to presentation of the symptoms was defined as time from the onset of symptoms to arrival in the hospital. Door to balloon time is the time starting from arrival in the hospital to first balloon inflation during the procedure of primary percutaneous coronary intervention. The primary end point was procedural success and in-hospital mortality. Outcome (primary and secondary) - An outcome variable of interest in the trial (also called an end point). Differences between groups in the outcome variable(s) are believed to be the result of the differing interventions. The primary outcome is the outcome of greatest importance. Data on secondary outcomes are used to evaluate additional effects of the intervention27.


It was a descriptive cross sectional study carried out at cardiology department of Armed Forces Institute Cardiology and National Institute of Heart Diseases (AFIC/NIHD) from October 2011 to January 2016. Patients with acute ST segment elevation myocardial infarction (STEMI) reporting to the emergency department of AFIC/NIHD were included in the study. Acute STEMI was diagnosed on the basis of history of chest pain of 1mm in 2 or more contiguous leads or new left bundle branch block25. Patients who had history of CABG, thrombolytic therapy and coronary angioplasty, suspicious with MI but normal, and those patients, who were taken to cath lab for the purpose of P.PCI and were decided and taken out to be surgical cases or had normal coronary angiograms, were excluded.

Data source and study sample

Cardiac cath lab registry is an initiative of the Armed Forces Institute Cardiology and National Institute of Heart Diseases, which is basically the modification of American College of Cardiology (ACC) Foundation and the Society for Cardiovascular Angiography and Interventions registry. Cath P.PCI registry has been approved from institutional ethical review board in 2011. Data is entered on SPSS version-22 software. Data quality assurance is achieved by proper management of data entry staff and it gets validated on monthly basis. A descriptive study regarding the procedural outcome has been published in 201422. This article is an update on primary and secondary outcomes of cath primary PCI and our purpose is to determine primary percutaneous coronary intervention success rate in our population.

Total of 2136 patients were included in the study through non-probability consecutive sampling. Written consent was taken and signed from the patient himself or from the available patient attendee. In this study we determined the outcome of patients undergoing P.PCI and to measure the success rate of primary PCI procedure at AFIC/NIHD. We examined 2,136 patients undergoing P.PCI for STEMI at AFIC/NIHD Rawalpindi in the Catheterization lab PPCI Registry between Oct 2011 and Dec 2016. Patients were grouped on the basis of success rate and in-hospital mortality and their outcome was determined by calculating p-values. The temporal trend in the rate of radial versus femoral approach was determined. We compared mortality and success rate with age, gender, co-morbidities, clinical characteristics and complications so that we can find the significant factors involved in success of patients having primary percutaneous coronary infarction.

All these patients underwent primary PCI as a mode of reperfusion according to set protocols. All patients received 300 mg aspirin, loading with 600 mg of Clopidogeral and an intravenous I/V bolus of unfractionated heparin at the dose of 70 IU/Kg body weight. Patients were shifted to catheterization laboratory. In our study population the commonest access site was Right radial approach. Angiography followed by primary PCI was performed according to set protocol of the hospital26.

Glycoprotein IIb/IIIa inhibitors were given in the form of two I/V boluses during the procedure and as an intravenous infusion post procedurally to all patients in the absence of contraindications. Other medication, selections of stent, use of thrombectomy device, temporary pacemaker (TPM), intra-aortic balloon pump (IABP) and ventilatory support was left to the discretion of the operator. Coronary flow in the infarct related artery was assessed visually by the operator according to the TIMI grading system on a scale of 0 to 3 before and after the PCI22 25. At the completion of procedure the patients were nursed in cardiac care unit (CCU) to coronary step down unit. These patients were observed indoor, generally for 48 to 72 hours before discharge. These patients were prescribed aspirin 150mg daily for the first month followed by 75mg daily indefinitely and Clopidogeral 75 mg for 3 months in case of bare metal stents and for one year in case of drug eluting stents22.

Table-1: Demographic and clinical history of primary PCI (n=2136).


Variables Vav###p-pvalue




21-38###01 (4%)###25 (96%)

39-57###08 (1.6%)###472 (98.4%)###0.783

58-75###29 (2.1%)###1353 (97.9%)

>76###06 (2.5%)###228 (97.5%)


Male###36 (81.9%)###1935 (98.2%)###0.017

Female###08 (18.1%)###156 (95.1%)

###History and Co-Morbidities

Diabetes###09 (2.4%)###368 (97.6%)###0.554

Hypertension###11 (1.8%)###596 (98.1%)###0.736

Smoking###12 (1.89%)###623 (98.1%)###0.868

Family history###02 (0.62%)###320 (99.3%)###0.028

History of CABG###01 (1.4%)###70 (98.6%)###0.978

PCI in past###01 (1.12%)###88 (98.8%)###0.810

Presenting Symptoms

Chest pain###44 (2%)###2095 (98%)###0.979

Dysponea###00 (0%)###01 (100%)

Data was extracted from cardiology data base registry retrospectively. Data collection performa was developed comprising demographics, co-morbidities, ECG measures, cardiogenic shock (defined as a systolic blood pressure of 90 mmHg), clinical findings, procedural details, timings and outcome variables.

Data entries were done on statistical package for social sciences software (SPSS) and Descriptive statistics like mean, median, S.D and percentages for gender, co-morbid, cardiogenic shock, various procedural variables and mortality were applied for qualitative and quantitative variables by using SPSS version-22. Chi-square test and independent sample T-test were used to calculate the p-values. p-value <0.05 is considered to be significant.


Total of 2136 patients were included in this study. As mentioned in table -1and2 the mean age was 59 +- 10.88 years. Patients of age 58yr and above were having high mortality rate (p-value<0.783). The overall mortality was more in males 36 (81.9%) than in females 08 (18.1%) and 0.017. Clinical characteristics and co-morbidities including diabetes in 378 (17.6%) patients (p<0.554), 608 (28.4%) were hypertensive (p<0.736), and 637 (29.7%) patients were smokers (p <0.868). Family history of ischemic heart disease was positive in 323 (15.1%) patients, which is a significant factor with the p - value=0.028. Left ventricular failure was in 37 (2.1%) no of patients with the p-value of 0.09. Cardiogenic shock was associated with high mortality 43 (2%) with the p-value of 0.800).

The Median time from the onset of symptoms to the arrival in the hospital was 210 +- 562.8 min (p < 0.001) and median door to balloon time was 56.25 +- 2.6 min (p <0.566).

Table-2: Clinical findings and cardiac complications of primary PCI (n=2136).

Cardiogenic shock###06 (13.9%)###37 (86.1%)###0.001

Pulmonary edema (LVF)###37 (2.1%)###1711 (97.8%)###0.900


Normal###07(1%)###698 (99%)###0.001

Rhythm disturbance###05 (3.26%)###148 (96.7%)


Systolic###106 +- 26.27###126.2 +- 24.7###0.001

Diastolic###87.3 +- 109.4###79.33 +- 16.8

Duration of symptoms###709.8 +- 1359.69###343.2 +- 532.2###0.001

Door to balloon time###56.25 +- 2.6###53.28 +- 32.4###0.566

Access site:

Radial###38 (1.9%)###1938 (98.1%)###0.407

Femoral###06 (4%)###146 (96%)

Multi vessel disease###33 (2.67%)###1202 (97.3%)###0.029

Visible thrombus###06 (1.6%)###375 (98.4%)###0.555

Thrombus aspiration###01 (1.3%)###74 (98.7%)###1.000

Culprit artery:

LAD###26 (2.3%)###1079 (97.6%)


RCA###08 (1.21%)###650 (98.8%)

LCX###02 (1.15%)###172 (98.8%)

POBA###03 (4.7%)###61 (95.3%)###0.134

Type of stent:

Drug eluting stent (DES)###15 (1.6%)###917 (98.4%)###0.002

Bare metal stent (BMS)###19 (2%)###929 (98%)

TPM###13 (16%)###68 (84%)###<0.001

No-Reflow###05 (11.4%)###13 (0.6%)###0.407). Left anterior descending (LAD) was the commonest infarct related artery accounting for culprit artery in 1115 (56.1%) followed by right coronary artery (RCA) and left circumflex artery (LCX) in 659 (33.2%) and 174 (8.8%) cases respectively with the p value of <0.001. Out of 44 mortality cases, 33 (75%) of patients were having multi vessel disease (defined as [greater than or equal to] 50% stenosis in [greater than or equal to] two epicardial arteries) and it was found to be a significant factor (p <0.015). 381 (17.8%) patients had visible thrombus whereas thrombectomy device was used only in 75 (3.5%) patients. 308 (14.4%) patients received GP IIb IIIa inhibitors. Angioplasty with stenting and POBA only was done in 1954 (91%) and 64 (3%) patients respectively.

Drug eluting stents (DES) were used in 932 (43.5%) and bare metal stents were deployed in 950 (44.3%) patients. TPM was inserted in 81 (3.8%) patients and rhythm disturbances were observed in 156 (7.2%). No-reflow was measured and observed in 05 (11.4%) patients and then managed accordingly (p <0.001). Intra-aortic balloon pump was used in 35 (1.6%) patients. Overall mortality rate was 44 (2.1%).


Using data from a broadly representative contemporary primary PCI registry, we are reporting several remarkable observations. This study was done amongst the patients who presented to the Tertiary Cardiac Care Institute with ST elevation MI and who were provided with PPCI to determine about the procedural outcomes and in-hospital mortality. Around 59 years was the mean age of the study population. Studies from all over the world had shown similar age group having STEMI15, although some studies conducted in western countries showed older mean age group17. Males were predominant in this cohort, their preponderance was around 81.9% (p <0.017), while in other studies it was around 70% - 80%. The important factors to such an out of proportion of male preponderance were entitlement of large number of serving, retired, military and civilian males 19. Hafeez et al reported mean age of patients suffering STEMI were 58+- 11 years and 78% of them were males.

In our study population 608 (28.4%) were hypertensive, 378 (17.6%) were diabetic and 637 (29.7%) were smokers. Their results are similar to other regional and international studies. Anterior myocardial infarction was the commonest followed by inferior wall MI. In our study cohort mean presenting time to onset of symptoms was 5.84+-9.37hrs, while Arshad et al had shown a median presenting time since the onset of symptoms of 3.8 hrs ranging from two to 8.5 hrs 18. In our cohort door to balloon time was around 1hr because of availability of expert staff, close proximity of the cath lab to the ER provide a shorter door to balloon time. Farman et al., had proven a mean door to balloon time of 98.4 minutes14. Menees et al., observed door to balloon time using data from 96,738 admitted patients with STEMI who underwent PPCI from Jul 2005 to Jun 2009 at 515 different hospitals and observed median DTBT vary from 83 in 1st year to 67 minutes in the last year of study.

American heart association/American cardiac center (AHA / ACC) endorsed a class-I recommendation for DTBT of 97 minutes or less4. Because of this recommendation given by AHA / ACC Door to balloon time has become the focus of quality improvement initiative.

LAD was found to be the commonest infarct related artery with a percentage of 56.1% (1115) followed RCA 659 (33.2%) and LCX 174 (7.9%) with similar findings by other investigators14. Hunain et al demonstrated procedural success rate of 97.1%. Similar success rate was quoted by Jaffery et al (97.1%), Farman et al (98.2%), Shaikh et al (97%) and Arshad et al (98.1%) from private and public sectors hospital in Karachi 20,12,14,18. Jaffery et al quoted in-hospital mortality of almost 8.3%, out of which 43.9% mortality cases were of Cardiogenic shock and 2.1% of non shock patients. Whether, Hunain et al from the same centers documented 2.9% mortality. In our study mortality cases were 44 (2.1%), out of which 6(13.9%) were had Cardiogenic shock and it was a significant finding is p-value was <0.001.

In our study 2142 stents were deployed out of which 948 (44.3%) were bare metal stents and 932 (43.5%) were drug eluting stent, although in some other studies 42.7% were bare metal stents and 57.3% were drug-eluting stents21. Stent thrombosis is a major complication particularly after primary percutaneous coronary intervention in STEMI. No study was found that has looked for sub acute stent thrombosis (SAT) in a heterogeneous group of patients who underwent PCI for ACS and stable CAD.

Majority of our patients had primary PCI for STEMI and we found that 2.4% of our patients developed either definite or probable SAT.21, 23.


Our study represents outcomes of primary PCI at a tertiary care centre. We found that indications and outcome in our patients are comparable to international data. The results of our study suggest that favorable outcome with PCI can be achieved in our setting21.


This study has no conflict of interest to declare by any author.


I would like to take this opportunity to express my profound gratitude and deep regard to Mr. Masood-Ur-Rehman for his input in providing valuable assistance to the undertaking of the research summarized.


1. Ohira T, Iso H. Cardiovascular disease epidemiology in Asia: an overview. Circ J. 2013; 77(7):1646-52.

2. Hata J1, KiyoharaY.Epidemiology of stroke and coronary artery disease in Asia. Circ J. 2013; 77(8): 1923-32.

3. Badimon L, Padro T, Vilahur G. Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. Eur Heart J Acute Cardiovasc Care. 2012 Apr;1(1):60-74.

4. Kushner FG, Hand M, Smith SC Jr, King SB 3rd, Anderson JL, Antman EM, et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines 2009 Focused Updates: ACC/AHA Guidelines for the management of patients with st-elevation myocardial infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on percutaneous coronary intervention (updating the 2005 Guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009 Dec 1;120(22):2271-306.

5. Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, et al. Task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012; 33(20): 2569-619.

6. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet. 2003 Jan 4; 361(9351): 13-20.

7. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003 Aug 21;349(8):733-42

8. Widimsky P, Wijns W, Fajadet J, de Belder M, Knot J, Aaberge L Reperfusion therapy for ST elevation acute myocardial infarction in Eu rope: description of the current situation in 30 countries. Eur Heart J. 2010; 31(8):943-57.

9. Lassen JF, Botker HE, Terkelsen CJ.Timely and optimal treatment of patients with STEMI. Nat Rev Cardiol. 2013 Jan; 10(1):41-8.

10. ThorstedSorensen J, Steengaard C, Holmvang L, Okkels Jensen L, Terkelsen CJ. Primary percutaneous coronary intervention as a national Danish reperfusion strategy of ST-elevation myocardial infarction. Ugeskr Laeger. 2013 Jan 21; 175(4):181-5.

11. Hafeez S, Javed A, Kayani AM. Clinical profile of patients presenting with acute ST elevation myocardial infarction. J Pak Med Assoc. 2010 Mar; 60(3): 190-3.

12. Jafary FH, Ahmed H, Kiani J. Outcomes of primary percutaneous coronary intervention at a joint commission international accredited hospital in a developing Primary PCI Pak Armed Forces Med J 2014; 1(1): S80-85 S85 country --can good results, possibly similar to the West, be achieved?J Invasive Cardiol. 2007; 19(10):417-23.

13. Shaikh AH1, Siddiqui MS, Hanif B, Malik F, Hasan K, Adhi F. Outcomes of primary percutaneous coronary intervention (PCI) in a tertiary care cardiac centre. J Pak Med Assoc. 2009 Jul; 59(7):426-9.

14. Farman MT, Sial JA, Khan NU, Rizvi SN, Saghir T, Zaman KS. Outcome of primary percutaneous coronary intervention at public sector tertiary care hospital in Pakistan. J Pak Med Assoc. 2011 Jun;61(6):575-81.

15. Mandelzweig L, Battler A, Boyko V, Bueno H, Danchin N, Filippatos G, et al Euro Heart Survey Investigators. The second Euro Heart Survey on acute coronary syndromes: Characteri stics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J. 2006 Oct; 27(19): 2285-93.

16. Steg PG, Goldberg RJ, Gore JM, Fox KA, Eagle KA, Flather MD, et alBaseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE).Am J Cardiol. 2002 Aug 15; 90(4): 358-63.

17. Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Reddy KS, et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data.Lancet. 2008 Apr 26; 371(9622): 1435-42.

18. Arshad S, Dhakam S, Awan S. Outcomes in ST elevation myocardial infarction; a comparison of a tertiary care center in Pakistan with European centers.J Pak Med Assoc. 2011 Dec; 61(12):1215-9.

19. Menees DS, Peterson ED, Wang Y, Curtis JP, Messenger JC, Rumsfeld JS, et al. Door - to balloon time and mortality among patients undergoing primary PCI. N Engl J Med. 2013 Sep 5; 369(10): 901-9

20. Hussain S, Kayani AM, Munir R. Trans-radial primary percutaneous coronary intervention in ST Elevation Myocardial Infarction.J Coll, Physicians Surg Pak. 2014 Feb; 24(2): 78-81.

21. Muhammad Shamim Siddiqui, Ayaz Hussain Shaikh, Bashir Hanif, Hammad Ali, Syed Muhammad Faisal Hussain, Sahr Sami, Mehreen Kisat; Procedure indications and outcome of percutaneous coronary interventions in a tertiary care hospital. J Pak Med Association; July 2010. Vol. 60, No. 7.

22. Naseer Ahmad Samore, Shahid Abbas, Khurram Shahzad, Sohail Aziz, Muhammad Qaiser Khan, Abdul Hameed Siddiqui, Muhammad Nadir Khan, Syed Mohammad Imran Majeed; procedural outcome of primary pci inst-segment elevation myocardial infarction at AFIC and NIHD rawalpindi - Pakistan. Mar 2014; Primary PCI Pak Armed Forces Med J 2014; 1(1): S80-85 S80.

23. Dmitri V. Baklanov, MD, Lisa A. Kaltenbach, MS, Steven P. Marso, MD, Sumeet S. Subherwal, MD, Dmitriy N. Feldman, MD, Kirk N. Garratt, MD, Jeptha P. Curtis, MD, John C. Messenger, MD, Sunil V. Rao, MD; The Prevalence and Outcomes of Transradial Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction---Analysis From the National Cardiovascular Data Registry (2007 to 2011). Journal of the American College of Cardiology; Vol. 61, No. 4, 2013; ISSN 0735-1097/$36.00 by Elsevier Inc.

24. Rao SV, Cohen MG, Kandzari DE, Bertrand OF, Gilchrist IC. The transradial approach to percutaneous coronary intervention: historical perspective, current concepts, and future directions. J Am Coll Cardiol 2010; 55: 2187-95.

25. Jang JS, Jin HY, Seo JS, et al. Transradial versus transfemoral approach for primary percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis. Euro-Intervention 2012; 8:501-10.

26. Rajesh V. Swaminathan, MD, Tracy Y. Wang, MD, MHS, MSC, Lisa A. Kaltenbach, MS, Luke K. Kim, MD, Robert M. Minutello, MD, Geoffrey Bergman, MD, S. Chiu Wong, MD, Dmitriy N. Feldman, MD. Non-system Reasons for Delay in Door-to-Balloon Time and Associated In-Hospital Mortality, A Report From the National Cardiovascular Data Registry; 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. Vol. 61, No. 16, 2013.

COPYRIGHT 2016 Asianet-Pakistan
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Pakistan Armed Forces Medical Journal
Geographic Code:9PAKI
Date:Apr 30, 2016

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters